SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    S. Taylor, A review of equine sepsis, Equine Veterinary Education, 2015, 27, 2
  2. 2
    Carolina Castagnetti, Jole Mariella, Anti-inflammatory Drugs in Equine Neonatal Medicine. Part I: Nonsteroidal Anti-inflammatory Drugs, Journal of Equine Veterinary Science, 2015, 35, 6, 475

    CrossRef

  3. 3
    Vanessa L. Cook, Anthony T. Blikslager, The use of nonsteroidal anti-inflammatory drugs in critically ill horses, Journal of Veterinary Emergency and Critical Care, 2015, 25, 1
  4. 4
    Jon Palmer, Update on the Management of Neonatal Sepsis in Horses, Veterinary Clinics of North America: Equine Practice, 2014, 30, 2, 317

    CrossRef

  5. 5
    Katharina L. Lohmann, Michelle H. Barton, Equine Infectious Diseases, 2014,

    CrossRef

  6. 6
    Kevin Corley, Gayle Hallowell, Equine Acute Abdomen, 2014,

    CrossRef

  7. 7
    C. DONALISIO, R. BARBERO, B. CUNIBERTI, C. VERCELLI, M. CASALONE, G RE, Effects of flunixin meglumine and ketoprofen on mediator production in ex vivo and in vitro models of inflammation in healthy dairy cows, Journal of Veterinary Pharmacology and Therapeutics, 2013, 36, 2
  8. 8
    A.E. Page, L.H. Fallon, U.K. Bryant, D.W. Horohov, T.W. Luna, P.S. Marsh, N.M. Slovis, K.A. Sprayberry, A.T. Loynachan, Acute Deterioration and Death with Necrotizing Enteritis Associated with Lawsonia intracellularis in 4 Weanling Horses, Journal of Veterinary Internal Medicine, 2012, 26, 6
  9. You have free access to this content9
    J. H. Foreman, B. E. Bergstrom, K. S. Golden, J. J. Roark, D. S. Coren, C. R. Foreman, S. A. Schumacher, Dose titration of the clinical efficacy of intravenously administered flunixin meglumine in a reversible model of equine foot lameness, Equine Veterinary Journal, 2012, 44,
  10. 10
    Bianca Patan-Zugaj, Felicia C. Gauff, Theresia F. Licka, Effects of the addition of endotoxin during perfusion of isolated forelimbs of equine cadavers, American Journal of Veterinary Research, 2012, 73, 9, 1462

    CrossRef

  11. 11
    Joanne Hardy, Peter C. Rakestraw, Equine Surgery, 2012,

    CrossRef

  12. 12
    Michelle Henry Barton, John F. Peroni, Equine Surgery, 2012,

    CrossRef

  13. 13
    Diagnosis and Management of Lameness in the Horse, 2011,

    CrossRef

  14. 14
    Christopher C. Pollitt, Michelle B. Visser, Carbohydrate Alimentary Overload Laminitis, Veterinary Clinics of North America: Equine Practice, 2010, 26, 1, 65

    CrossRef

  15. 15
    Thomas J. Divers, Clinical Application of Current Research Findings Toward the Prevention and Treatment of Acute Laminitis in Horses With Systemic Inflammatory Diseases: An Internist’s Perspective, Journal of Equine Veterinary Science, 2010, 30, 9, 517

    CrossRef

  16. 16
    James K. Belknap, The Pharmacologic Basis for the Treatment of Developmental and Acute Laminitis, Veterinary Clinics of North America: Equine Practice, 2010, 26, 1, 115

    CrossRef

  17. 17
    Gal Kelmer, Update on Treatments for Endotoxemia, Veterinary Clinics of North America: Equine Practice, 2009, 25, 2, 259

    CrossRef

  18. 18
    Thomas J. Divers, COX Inhibitors: Making the Best Choice for the Laminitic Case, Journal of Equine Veterinary Science, 2008, 28, 6, 367

    CrossRef

  19. 19
    Sébastien Buczinski, Søren R. Boysen, Gilles Fecteau, Mechanical ventilation of a cloned calf in respiratory failure, Journal of Veterinary Emergency and Critical Care, 2007, 17, 2
  20. 20
    Katharina L. Lohmann, Michelle Henry Barton, Equine Infectious Diseases, 2007,

    CrossRef

  21. 21
    Tony D. Mogg, Susanne Dykgraaf, Actinobacillus Peritonitis in a Warmblood Gelding, Veterinary Clinics of North America: Equine Practice, 2006, 22, 1, e9

    CrossRef

  22. 22
    Rachel P. Atherton, M. Furr, Endotoxin release after antimicrobial treatment in sick foals is mediated by antimicrobial class, Journal of Equine Veterinary Science, 2006, 26, 8, 356

    CrossRef

  23. 23
    Jonathan H. Magid, Pneumonia and Pleuritis in a Mare, Veterinary Clinics of North America: Equine Practice, 2006, 22, 1, 247

    CrossRef

  24. 24
    Equine Neonatal Medicine, 2006,

    CrossRef

  25. 25
    Joanne Hardy, Peter C. Rakestraw, Equine Surgery, 2006,

    CrossRef

  26. 26
    Susan C. Eades, Rustin M. Moore, Equine Surgery, 2006,

    CrossRef

  27. 27
    A. H. WERNERS, S. BULL, J. FINK-GREMMELS, Endotoxaemia: a review with implications for the horse, Equine Veterinary Journal, 2005, 37, 4
  28. 28
    BW SYKES, MO FURR, Equine endotoxaemia - A state-of-the-art review of therapy, Australian Veterinary Journal, 2005, 83, 1-2
  29. 29
    R. Wayne Waguespack, Anne Cochran, James K. Belknap, Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses, American Journal of Veterinary Research, 2004, 65, 12, 1724

    CrossRef

  30. 30
    M. H. BARTON, A. PARVIAINEN, N. NORTON, Polymyxin B protects horses against induced endotoxaemia in vivo, Equine Veterinary Journal, 2004, 36, 5
  31. 31
    Louise L. Southwood, Postoperative management of the large colon volvulus patient, Veterinary Clinics of North America: Equine Practice, 2004, 20, 1, 167

    CrossRef

  32. 32
    K. E. SULLINS, N. A. WHITE, C. S. LUNDIN, R. DABAREINER, G. GAULIN, Prevention of ischaemia-induced small intestinal adhesions in foals, Equine Veterinary Journal, 2004, 36, 5
  33. 33
    Marie-France Roy, Sepsis in adults and foals, Veterinary Clinics of North America: Equine Practice, 2004, 20, 1, 41

    CrossRef

  34. 34
    Samuel L. Jones, Anthony T. Blikslager, Equine Internal Medicine, 2004,

    CrossRef

  35. 35
    Patricia M. Dowling, Equine Internal Medicine, 2004,

    CrossRef

  36. 36
    Debra C. Sellon, Equine Internal Medicine, 2004,

    CrossRef

  37. 37
    Michelle H. Barton, Lisa Williamson, Stephanie Jacks, Natalie Norton, Effects on plasma endotoxin and eicosanoid concentrations and serum cytokine activities in horses competing in a 48-, 83-, or 159-km endurance ride under similar terrain and weather conditions, American Journal of Veterinary Research, 2003, 64, 6, 754

    CrossRef

  38. 38
    Samuel L Jones, Treatment of acute and chronic gastrointestinal inflammation, Veterinary Clinics of North America: Equine Practice, 2003, 19, 3, 697

    CrossRef

  39. 39
    James N Moore, Michelle Henry Barton, Treatment of endotoxemia, Veterinary Clinics of North America: Equine Practice, 2003, 19, 3, 681

    CrossRef

  40. 40
    Erin Malone, Lynelle Graham, Management of gastrointestinal pain, Veterinary Clinics of North America: Equine Practice, 2002, 18, 1, 133

    CrossRef

  41. 41
    Valentine S. Moses, Alicia L. Bertone, Nonsteroidal anti-inflammatory drugs, Veterinary Clinics of North America: Equine Practice, 2002, 18, 1, 21

    CrossRef

  42. 42
    Joanne Hardy, Peter C. Rakestraw, Postoperative management for colics, Clinical Techniques in Equine Practice, 2002, 1, 3, 188

    CrossRef

  43. 43
    Anna K. Parviainen, Michelle H. Barton, Natalie N. Norton, Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses, American Journal of Veterinary Research, 2001, 62, 1, 72

    CrossRef

  44. 44
    R. J. MacKAY, C. A. DANIELS, H. F. BLEYAERT, J. E. BAILEY, K. D. GILLIS, A. M. MERRITT, T. L. KATZ, J. C. JOHNSON, K. C. THOMPSON, Effect of eltenac in horses with induced endotoxaemia, Equine Veterinary Journal, 2000, 32, S32
  45. 45
    G. A. Meyer, R. R. Hanson, Nonstrangulating obstruction of the small intestine in the horse, Equine Veterinary Education, 2000, 12, 3
  46. 46
    J. N. Moore, Michelle H. Barton, An update on endotoxaemia Part 2: treatment and the way ahead, Equine Veterinary Education, 1999, 11, 1
  47. 47
    Katherine T. Gibson, Catherine M. Steel, Strangulating obstructions of the large colon in mature horses, Equine Veterinary Education, 1999, 11, 5
  48. 48
    C. H. Pickersgill, Celia M. Marr, Carbohydrate overload with secondary endotoxaemia in a pony, Equine Veterinary Education, 1998, 10, 6
  49. 49
    AJ DART, DR HODGSON, Role of prokinetic drugs for treatment of postoperative ileus in the horse, Australian Veterinary Journal, 1998, 76, 1
  50. 50
    AJ DART, DR HODGSON, Role of prokinetic drugs for treatment of postoperative ileus in the horse, Australian Veterinary Journal, 1998, 76, 1, 25

    CrossRef

  51. 51
    Debra C. Sellon, Thrombocytopenia in horses, Equine Veterinary Education, 1998, 10, 3
  52. 52
    GARY M. BAXTER, Alterations of Endothelium-Dependent Digital Vascular Responses in Horses Given Low-Dose Endotoxin, Veterinary Surgery, 1995, 24, 2
  53. 53
    James N. Moore, ENDOTOXAEMIA: RECENT ADVANCES IN PATHOPHYSIOLOGY AND TREATMENT, Veterinary Anaesthesia and Analgesia, 1994, 21, 2
  54. 54
    S. RUBIE, N. E. ROBINSON, M. STOLL, R. V. BROADSTONE, F. J. DERKSEN, Flunixin meglumine blocks frusemide-induced bronchodilatation in horses with chronic obstructive pulmonary disease, Equine Veterinary Journal, 1993, 25, 2
  55. 55
    S. D. Semrad, O. N. Harris, Serum thromboxane generation by platelets in calves and adult cows, Comparative Haematology International, 1993, 3, 1, 52

    CrossRef

  56. 56
    Robert D. Welch, Jeffrey P. Watkins, Tex S. Taylor, Noah D. Cohen, G. Kent Carter, Disseminated Intravascular Coagulation Associated with Colic in 23 Horses (1984–1989), Journal of Veterinary Internal Medicine, 1992, 6, 1
  57. 57
    H. CAMBRIDGE, P. LEES, R. E. HOOKE, C. S. RUSSELL, Antithrombotic actions of aspirin in the horse, Equine Veterinary Journal, 1991, 23, 2
  58. 58
    P. MULVILLE, Equine monocytic ehrlichiosis (Potomac horse fever): a review, Equine Veterinary Journal, 1991, 23, 6
  59. 59
    Q. A. McKELLAR, J. A. BOGAN, R.-L FELLENBERG, B. LUDWIG, G. D. CAWLEY, Pharmacokinetic, biochemical and tolerance studies on carprofen in the horse, Equine Veterinary Journal, 1991, 23, 4
  60. 60
    J. N. KING, E. L. GERRING, Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone, Equine Veterinary Journal, 1989, 21, S7
  61. 61
    K. Gary Magdesian, Foals are not just mini horses,
  62. 62
    Stuart Clark-Price, Nonsteroidal Anti-Inflammatory Drugs and Corticosteroids,